Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03071393 · ClinicalTrials.gov registry record · NA
Intermittent Hypoxia to Enhance Motor Function After Spinal Cord Injury
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT03071393: Completed NA study, sponsored by University of Florida.
NCT03071393 is a NA study that has completed, run by University of Florida. The registered enrollment target is 17 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03071393, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This study will examine if acute intermittent hypoxia (brief episodes of breathing lower oxygen), which has been shown to enhance plasticity and motor output, can enhance functional outcomes and muscle activation in individuals with spinal cord injury. Our aim is to assess breathing, sitting, standing and walking functional ability before and after acute intermittent hypoxia, compared to a sham treatment. This information may be useful in advancing rehabilitation for people with spinal cord injuries.
Primary Outcome
An assessment of inspiratory muscle strength.
Interventions
- DEVICE Hypoxia via Hypoxico Hyp-123
- DEVICE Sham via Hypoxico Hyp-123
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2017-07-10 |
| Est. Completion | 2020-09-01 |
| Phase | NA |
What the finished NCT03071393 record still lists
NCT03071393 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 17 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Hypoxia via Hypoxico Hyp-123 is the first listed.
NCT03071393 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03071393 about?
NCT03071393 is a clinical study titled "Intermittent Hypoxia to Enhance Motor Function After Spinal Cord Injury". This study will examine if acute intermittent hypoxia (brief episodes of breathing lower oxygen), which has been shown to enhance plasticity and motor output, can enhance functional outcomes and muscle activation in individuals with spinal cord injury. Our aim is to assess breathing, sitting, standi...
What is the current status of trial NCT03071393?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2017-07-10. Estimated completion is 2020-09-01.
What interventions are being tested in trial NCT03071393?
The interventions under investigation include: Hypoxia via Hypoxico Hyp-123 (DEVICE), Sham via Hypoxico Hyp-123 (DEVICE).
Who is sponsoring clinical trial NCT03071393?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03071393's enrollment target sits among peer trials
17 1871st of 2000 higher than 130 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02090140 · 17 participants · NA
Microfracture Versus Adipose Derived Stem Cells for the Treatment of Articular Cartilage Defects
- NCT03317860 · 17 participants · NA
Improving Measurement and Treatment of Post-stroke Neglect
- NCT04356469 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Non-Malignant Hematological Disorders in Children
- NCT04414046 · 17 participants · Phase 2
TCR Alpha Beta T-cell Depleted Haploidentical HCT in the Treatment of Primary Immunodeficiency and Inherited Metabolic Disorders in Children
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI